SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes

被引：0
|
作者：
R. Camille Brewer
William H. Robinson
Tobias V. Lanz
机构：
[1] Stanford University School of Medicine,Division of Immunology and Rheumatology, Department of Medicine
[2] VA Palo Alto Health Care System,Geriatric Research, Education, and Clinical Centers (GRECC)
来源：
Signal Transduction and Targeted Therapy | / 7卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination
    De Maria, Andrea
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (09): : 897 - 898
  • [22] Monoclonal antibodies: a remedial approach to prevent SARS-CoV-2 infection
    Kumar, Sonu
    Dutta, Debrupa
    Ravichandiran, Velayutham
    Sukla, Soumi
    3 BIOTECH, 2022, 12 (09)
  • [23] Using SARS-CoV-2 nucleoprotein antibodies to detect (re)infection
    Hoeve, Christel E.
    Neppelenbroek, Nienke
    Vos, Eric R. A.
    Huiberts, Anne J.
    Andeweg, Stijn P.
    den Hartog, Gerco
    van Binnendijk, Robert
    de Melker, Hester
    van den Hof, Susan
    Knol, Mirjam
    EPIDEMIOLOGY & INFECTION, 2025, 153
  • [24] Safety of Monoclonal Antibodies in Children Affected by SARS-CoV-2 Infection
    Romani, Lorenza
    Carducci, Francesca Ippolita Calo
    Chiurchiu, Sara
    Cursi, Laura
    De Luca, Maia
    Di Giuseppe, Martina
    Krzysztofiak, Andrzej
    Lancella, Laura
    Palma, Paolo
    Vallesi, Leonardo
    Corsetti, Tiziana
    Campana, Andrea
    Nicastri, Emanuele
    Rossi, Paolo
    Bernardi, Stefania
    CHILDREN-BASEL, 2022, 9 (03):
  • [25] Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
    Lempp, Florian A.
    Soriaga, Leah B.
    Montiel-Ruiz, Martin
    Benigni, Fabio
    Noack, Julia
    Park, Young-Jun
    Bianchi, Siro
    Walls, Alexandra C.
    Bowen, John E.
    Zhou, Jiayi
    Kaiser, Hannah
    Joshi, Anshu
    Agostini, Maria
    Meury, Marcel
    Dellota, Exequiel, Jr.
    Jaconi, Stefano
    Cameroni, Elisabetta
    Martinez-Picado, Javier
    Vergara-Alert, Julia
    Izquierdo-Useros, Nuria
    Virgin, Herbert W.
    Lanzavecchia, Antonio
    Veesler, David
    Purcell, Lisa A.
    Telenti, Amalio
    Corti, Davide
    NATURE, 2021, 598 (7880) : 342 - +
  • [26] Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
    Wajnberg, Ania
    Amanat, Fatima
    Firpo, Adolfo
    Altman, Deena R.
    Bailey, Mark J.
    Mansour, Mayce
    McMahon, Meagan
    Meade, Philip
    Mendu, Damodara Rao
    Muellers, Kimberly
    Stadlbauer, Daniel
    Stone, Kimberly
    Strohmeier, Shirin
    Simon, Viviana
    Aberg, Judith
    Reich, David L.
    Krammer, Florian
    Cordon-Cardo, Carlos
    SCIENCE, 2020, 370 (6521) : 1227 - +
  • [27] SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
    Bongiovanni, Marco
    Spada, Elena
    De Angelis, Cristina
    Liuzzi, Gianmaria
    Giuliani, Giuseppe
    JOURNAL OF INFECTION, 2022, 84 (06) : E120 - E121
  • [28] Estimating decay curves of neutralizing antibodies to SARS-CoV-2 infection
    Poehler, Elliot
    Gibson, Liam
    Lustig, Audrey
    Moreland, Nicole J.
    McGregor, Reuben
    James, Alex
    MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA, 2022, 39 (04): : 368 - 381
  • [29] Neutralizing monoclonal antibodies for the treatment and prophylaxis of SARS-CoV-2 infection
    Bruzzesi, Elena
    Ranzenigo, Martina
    Castagna, Antonella
    Spagnuolo, Vincenzo
    NEW MICROBIOLOGICA, 2021, 44 (03): : 135 - 144
  • [30] Monoclonal antibodies: a remedial approach to prevent SARS-CoV-2 infection
    Sonu Kumar
    Debrupa Dutta
    Velayutham Ravichandiran
    Soumi Sukla
    3 Biotech, 2022, 12
12345